Cargando…
Mitotane Nanocarriers for the Treatment of Adrenocortical Carcinoma: Evaluation of Albumin-Stabilized Nanoparticles and Liposomes in a Preclinical In Vitro Study with 3D Spheroids
Adrenocortical carcinoma (ACC) is a heterogeneous malignancy related to poor prognosis and limited treatment options. The orphan drug mitotane (MT) is still a cornerstone in ACC therapy, however, its application is characterized by low aqueous solubility, poor bioavailability, and unfavorable pharma...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501383/ https://www.ncbi.nlm.nih.gov/pubmed/36145639 http://dx.doi.org/10.3390/pharmaceutics14091891 |
_version_ | 1784795461096308736 |
---|---|
author | Langer, Carolin Köll-Weber, Monika Holzer, Martin Hantel, Constanze Süss, Regine |
author_facet | Langer, Carolin Köll-Weber, Monika Holzer, Martin Hantel, Constanze Süss, Regine |
author_sort | Langer, Carolin |
collection | PubMed |
description | Adrenocortical carcinoma (ACC) is a heterogeneous malignancy related to poor prognosis and limited treatment options. The orphan drug mitotane (MT) is still a cornerstone in ACC therapy, however, its application is characterized by low aqueous solubility, poor bioavailability, and unfavorable pharmacokinetics, often resulting in below-target plasma concentrations or toxic side effects. Throughout the last decades, nanoparticulate formulations have become attractive carriers to improve anticancer therapy. In this study, injectable MT liposomes (DOPC-MT) and albumin-stabilized MT nanoparticles (BSA-MT) were investigated in depth with respect to their physicochemical properties, and their colloidal and therapeutical stability upon storage. Furthermore, in vitro cytotoxicity was evaluated using the ACC model cell line NCI-H295R for preparing multicellular tumor spheroids, and was compared to non-malignant human dermal fibroblasts. Our results clearly demonstrate that BSA-MT, unlike DOPC-MT, represents a stable and storable MT formulation with a high drug concentration in an aqueous medium. Dual centrifugation was established as a reproducible method for nanoparticle preparation. Although an efficient cytotoxic effect on ACC tumor spheroids was demonstrated, concomitant low toxicity to fibroblasts suggests that higher drug concentrations may be tolerated in vivo. Consequently, BSA-MT is a novel and promising therapeutical approach to address key challenges in MT treatment. |
format | Online Article Text |
id | pubmed-9501383 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95013832022-09-24 Mitotane Nanocarriers for the Treatment of Adrenocortical Carcinoma: Evaluation of Albumin-Stabilized Nanoparticles and Liposomes in a Preclinical In Vitro Study with 3D Spheroids Langer, Carolin Köll-Weber, Monika Holzer, Martin Hantel, Constanze Süss, Regine Pharmaceutics Article Adrenocortical carcinoma (ACC) is a heterogeneous malignancy related to poor prognosis and limited treatment options. The orphan drug mitotane (MT) is still a cornerstone in ACC therapy, however, its application is characterized by low aqueous solubility, poor bioavailability, and unfavorable pharmacokinetics, often resulting in below-target plasma concentrations or toxic side effects. Throughout the last decades, nanoparticulate formulations have become attractive carriers to improve anticancer therapy. In this study, injectable MT liposomes (DOPC-MT) and albumin-stabilized MT nanoparticles (BSA-MT) were investigated in depth with respect to their physicochemical properties, and their colloidal and therapeutical stability upon storage. Furthermore, in vitro cytotoxicity was evaluated using the ACC model cell line NCI-H295R for preparing multicellular tumor spheroids, and was compared to non-malignant human dermal fibroblasts. Our results clearly demonstrate that BSA-MT, unlike DOPC-MT, represents a stable and storable MT formulation with a high drug concentration in an aqueous medium. Dual centrifugation was established as a reproducible method for nanoparticle preparation. Although an efficient cytotoxic effect on ACC tumor spheroids was demonstrated, concomitant low toxicity to fibroblasts suggests that higher drug concentrations may be tolerated in vivo. Consequently, BSA-MT is a novel and promising therapeutical approach to address key challenges in MT treatment. MDPI 2022-09-07 /pmc/articles/PMC9501383/ /pubmed/36145639 http://dx.doi.org/10.3390/pharmaceutics14091891 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Langer, Carolin Köll-Weber, Monika Holzer, Martin Hantel, Constanze Süss, Regine Mitotane Nanocarriers for the Treatment of Adrenocortical Carcinoma: Evaluation of Albumin-Stabilized Nanoparticles and Liposomes in a Preclinical In Vitro Study with 3D Spheroids |
title | Mitotane Nanocarriers for the Treatment of Adrenocortical Carcinoma: Evaluation of Albumin-Stabilized Nanoparticles and Liposomes in a Preclinical In Vitro Study with 3D Spheroids |
title_full | Mitotane Nanocarriers for the Treatment of Adrenocortical Carcinoma: Evaluation of Albumin-Stabilized Nanoparticles and Liposomes in a Preclinical In Vitro Study with 3D Spheroids |
title_fullStr | Mitotane Nanocarriers for the Treatment of Adrenocortical Carcinoma: Evaluation of Albumin-Stabilized Nanoparticles and Liposomes in a Preclinical In Vitro Study with 3D Spheroids |
title_full_unstemmed | Mitotane Nanocarriers for the Treatment of Adrenocortical Carcinoma: Evaluation of Albumin-Stabilized Nanoparticles and Liposomes in a Preclinical In Vitro Study with 3D Spheroids |
title_short | Mitotane Nanocarriers for the Treatment of Adrenocortical Carcinoma: Evaluation of Albumin-Stabilized Nanoparticles and Liposomes in a Preclinical In Vitro Study with 3D Spheroids |
title_sort | mitotane nanocarriers for the treatment of adrenocortical carcinoma: evaluation of albumin-stabilized nanoparticles and liposomes in a preclinical in vitro study with 3d spheroids |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501383/ https://www.ncbi.nlm.nih.gov/pubmed/36145639 http://dx.doi.org/10.3390/pharmaceutics14091891 |
work_keys_str_mv | AT langercarolin mitotanenanocarriersforthetreatmentofadrenocorticalcarcinomaevaluationofalbuminstabilizednanoparticlesandliposomesinapreclinicalinvitrostudywith3dspheroids AT kollwebermonika mitotanenanocarriersforthetreatmentofadrenocorticalcarcinomaevaluationofalbuminstabilizednanoparticlesandliposomesinapreclinicalinvitrostudywith3dspheroids AT holzermartin mitotanenanocarriersforthetreatmentofadrenocorticalcarcinomaevaluationofalbuminstabilizednanoparticlesandliposomesinapreclinicalinvitrostudywith3dspheroids AT hantelconstanze mitotanenanocarriersforthetreatmentofadrenocorticalcarcinomaevaluationofalbuminstabilizednanoparticlesandliposomesinapreclinicalinvitrostudywith3dspheroids AT sussregine mitotanenanocarriersforthetreatmentofadrenocorticalcarcinomaevaluationofalbuminstabilizednanoparticlesandliposomesinapreclinicalinvitrostudywith3dspheroids |